William Binotti is a Boston, Massachusetts based male Ophthalmologist who is specialized in Ophthalmology. Active license number of William Binotti is 1023040 for Ophthalmology in Massachusetts. William Binotti is medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, patients can be prescribed vision services, including glasses and contact lenses.
Complete Profile:
William Binotti speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Ophthalmology
Credentials:
MD
Gender:
Male
Practice Address:
243 Charles St, Boston, Massachusetts, 02114-3002
Phone:
617-573-4443
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1033798152
NPI Enumeration Date:
06 Apr, 2021
NPI Last Update On:
09 Jul, 2025
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for William Binotti are as mentioned below.
License Number
Specialization
State
Status
1023040
Ophthalmology
Massachusetts
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
243 Charles St, Boston, Massachusetts
Zip:
02114-3002
Phone Number:
617-573-4443
Fax Number:
--
Patients can reach William Binotti at 243 Charles St, Boston, Massachusetts or can call to book an appointment on 617-573-4443. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 July, 2025.